UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance to rifampicin: a review

Journal of antibiotics, 2014-09, Vol.67 (9), p.625-630

Goldstein, Beth P

2014

Volltextzugriff (PDF)

Origin, structure, and activity in vitro and in vivo of dalbavancin

Journal of antimicrobial chemotherapy, 2005-03, Vol.55 (suppl-2), p.ii15-ii20

2005

Volltextzugriff (PDF)

Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue Infections

Clinical infectious diseases, 2003-11, Vol.37 (10), p.1298-1303

2003

Volltextzugriff (PDF)

A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis

Clinical infectious diseases, 2004-09, Vol.39 (6), p.770-775

2004

Volltextzugriff (PDF)

Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2021-2024

2004

Volltextzugriff (PDF)

Bactericidal Activity and Resistance Development Profiling of Dalbavancin

Antimicrobial Agents and Chemotherapy, 2007-04, Vol.51 (4), p.1150-1154

2007

Volltextzugriff (PDF)

Cross-Resistance of Escherichia coli RNA Polymerases Conferring Rifampin Resistance to Different Antibiotics

Journal of Bacteriology, 2005-04, Vol.187 (8), p.2783-2792

2005

Volltextzugriff (PDF)

Factors Influencing Broth Microdilution Antimicrobial Susceptibility Test Results for Dalbavancin, a New Glycopeptide Agent

Journal of Clinical Microbiology, 2007-10, Vol.45 (10), p.3151-3154

2007

Volltextzugriff (PDF)

Activity of Dalbavancin against Bacillus anthracis In Vitro and in a Mouse Inhalation Anthrax Model

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.991-996

2010

Volltextzugriff (PDF)

Anidulafungin versus Fluconazole for Invasive Candidiasis

The New England journal of medicine, 2007-06, Vol.356 (24), p.2472-2482

2007

Volltextzugriff (PDF)

Comparison of Dalbavancin MIC Values Determined by Etest (AB BIODISK) and Reference Dilution Methods Using Gram-Positive Organisms

Journal of Clinical Microbiology, 2006-08, Vol.44 (8), p.2988-2990

2006

Volltextzugriff (PDF)

Lysostaphin Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Aortic Valve Endocarditis

Antimicrobial Agents and Chemotherapy, 1998-06, Vol.42 (6), p.1355-1360

1998

Volltextzugriff (PDF)

Lysostaphin Treatment of Experimental Aortic Valve Endocarditis Caused by a Staphylococcus aureus Isolate with Reduced Susceptibility to Vancomycin

Antimicrobial Agents and Chemotherapy, 1999-07, Vol.43 (7), p.1754-1755

1999

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Modeling of Dalbavancin, a Novel Glycopeptide Antibiotic

Journal of clinical pharmacology, 2008-09, Vol.48 (9), p.1063-1068

2008

Volltextzugriff (PDF)

Disk Diffusion-Based Methods for Determining Candida parapsilosis Susceptibility to Anidulafungin

Antimicrobial Agents and Chemotherapy, 2003-09, Vol.47 (9), p.3018-3020

2003

Volltextzugriff (PDF)

In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide

Journal of antimicrobial chemotherapy, 2005-03, Vol.55 (suppl-2), p.ii21-ii24

2005

Volltextzugriff (PDF)

A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis

Journal of acquired immune deficiency syndromes (1999), 2008-07, Vol.48 (3), p.304-309

2008

Volltextzugriff (PDF)

Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)

Diagnostic microbiology and infectious disease, 2006-02, Vol.54 (2), p.149-153

2006

Volltextzugriff (PDF)

In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species

International journal of antimicrobial agents, 2006-02, Vol.27 (2), p.174-177

2006

Volltextzugriff (PDF)

New Semisynthetic Glycopeptides MDL 63, 246 and MDL 63, 042, and Other Amide Derivatives of Antibiotic A-40, 926 Active against Highly Glycopeptide-resistant VanA Enterococci

The Journal of Antibiotics, 1995/08/25, Vol.48(8), pp.869-883

1995

Volltextzugriff (PDF)

Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections

Diagnostic microbiology and infectious disease, 2006-02, Vol.54 (2), p.83-87

2006

Volltextzugriff (PDF)

Semisynthetic Derivatives of Purpuromycin as Potential Topical Agents for Vaginal Infections

Journal of medicinal chemistry, 1997-03, Vol.40 (6), p.967-971

1997

Volltextzugriff (PDF)

Components of the GE2270 complex produced by Planobispora rosea ATCC 53773

Journal of antibiotics, 1995-01, Vol.48 (9), p.1039-1042

1995

Volltextzugriff (PDF)

Antimicrobial Activities of Chemically Modified Thiazolyl Peptide Antibiotic MDL 62, 879 (GE2270A)

The Journal of Antibiotics, 1997/04/25, Vol.50(4), pp.344-349

1997

Volltextzugriff (PDF)

Deacylation of the Glycopeptide Antibiotic A40926 by Actinoplanes teichomyceticus ATCC 31121

The Journal of Antibiotics, 1996/06/25, Vol.49(6), pp.607-609

1996

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(115)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(92)
Humans
(64)
Female
(46)
Biological And Medical Sciences
(42)
Medical Sciences
(37)
Microbiology
(36)
Male
(35)
Anti-Bacterial Agents - Pharmacology
(27)
Pharmacology & Pharmacy
(25)
Pharmacology. Drug Treatments
(25)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(24)
Adult
(23)
Microbial Sensitivity Tests
(23)
Animals
(20)
Infectious Diseases
(19)
Middle Aged
(18)
Teicoplanin - Analogs & Derivatives
(17)
Infant, Newborn
(16)
Immunology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Resistance to rifampicin: a review

Origin, structure, and activity in vitro and in vivo of dalbavancin

Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue Infections

A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis

Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

Bactericidal Activity and Resistance Development Profiling of Dalbavancin

Cross-Resistance of Escherichia coli RNA Polymerases Conferring Rifampin Resistance to Different Antibiotics

Factors Influencing Broth Microdilution Antimicrobial Susceptibility Test Results for Dalbavancin, a New Glycopeptide Agent

Activity of Dalbavancin against Bacillus anthracis In Vitro and in a Mouse Inhalation Anthrax Model

Anidulafungin versus Fluconazole for Invasive Candidiasis

Comparison of Dalbavancin MIC Values Determined by Etest (AB BIODISK) and Reference Dilution Methods Using Gram-Positive Organisms

Lysostaphin Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Aortic Valve Endocarditis

Lysostaphin Treatment of Experimental Aortic Valve Endocarditis Caused by a Staphylococcus aureus Isolate with Reduced Susceptibility to Vancomycin

Pharmacokinetic-Pharmacodynamic Modeling of Dalbavancin, a Novel Glycopeptide Antibiotic

Disk Diffusion-Based Methods for Determining Candida parapsilosis Susceptibility to Anidulafungin

In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide

A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis

Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)

In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species

New Semisynthetic Glycopeptides MDL 63, 246 and MDL 63, 042, and Other Amide Derivatives of Antibiotic A-40, 926 Active against Highly Glycopeptide-resistant VanA Enterococci

Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections

Semisynthetic Derivatives of Purpuromycin as Potential Topical Agents for Vaginal Infections

Components of the GE2270 complex produced by Planobispora rosea ATCC 53773

Antimicrobial Activities of Chemically Modified Thiazolyl Peptide Antibiotic MDL 62, 879 (GE2270A)

Deacylation of the Glycopeptide Antibiotic A40926 by Actinoplanes teichomyceticus ATCC 31121

Suchergebnisse filtern